memo & hrc
Other studies

Time Study - Antihypertensive Study

In recent years, special monitors that can measure blood pressure throughout the day and the night have been developed. Results from studies using these monitors have suggested that night time blood pressure might be a better measurement of the benefits of blood pressure lowering. In addition, tablets taken at night lower night-time blood pressure more than tablets taken in the morning. The big question is, would night time dosing be better (or worse) than morning dosing in preventing the bad things associated with high blood pressure (such as strokes and heart attacks)?


Standard Care versus Celecoxib Outcome Trial (SCOT)

The SCOT study is designed to find out if celecoxib is definitely better, worse or just the same as the other available NSAIDs. Because SCOT will eventually involve many thousands of participants we will also be able to look at the relative safety of all the NSAIDs in common use. This information will be of great value to everyone who needs to take these drugs on a regular basis. It will allow doctors to make the best choice for people with arthritis, not just for their joint pains but also for their general health.


MEMO Safety Project

The MEMO Safety Project wants to engage patients in medicine safety and effectiveness. By collecting participants medical history it is hoped the data will shine a light on what medicines are most effective and what medicines have side effects.


Prevention And Treatment of Hypertension With Algorithm-based therapY (PATHWAY)

HRC is one of 8 UK centres taking part in the PATHWAY studies. PATHWAY comprises three clinical trials of licensed medicines, which aim to address some important areas of uncertainty in the current management of hypertension:
1. Monotherapy vs. dual therapy for initial treatment for hypertension
2. Optimal treatment of drug resistant hypertension
3. Comparison of single and combination diuretics in low-renin hypertension


Get Randomised Campaign

The get randomised campaign was designed to raise awareness and to get the general public involved in randomised clinical trials. This is a collaborative project between the Universities of Dundee, Edinburgh, Glasgow and Aberdeen.